3d
JW Pharmaceutical and JW Shinyak Hold Symposium on Benign Prostatic Hyperplasia Treatment "Truepass"
JW Pharmaceutical and JW Shinyak announced on the 10th that they held the "J STAR Symposium" at the Grand Walkerhill Seoul ...
An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your ...
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...
Prostate health is vital for men over fifty as conditions like BPH, prostatitis, and cancer can affect urinary function and ...
U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
In the Chinese population, the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio and the total cholesterol (TC)/HDL-C ratio are associated with an increased risk for benign ...
The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the ...
ProVerum Limited, a medical device company focused on innovative, safe, and effective solutions for treating benign prostatic hyperplasia (BPH), today announced that Jesse Litwak has joined the ...
Shares of PROCEPT BioRobotics (PRCT) fell 8% on Thursday after Leerink Partnerscdowngraded the stock to Market Perform from Outperform and lowered its price target to $29 from $31, citing growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results